Literature DB >> 28210531

The Daniel K. Inouye College of Pharmacy Scripts: Updates on Clostridium difficile Infection: Advances in Laboratory Testing to Aid Diagnosis and Treatment.

Louis Lteif1.   

Abstract

Clostridium difficile remains a major source of nosocomial infections and associated diarrhea. More recently, community-acquired cases are on the rise creating a concern for a serious public health threat. Appropriate infection control precautions as well as prevention and optimal management may help to avoid detrimental outbreaks. A key step is utilizing laboratory testing for quick and accurate diagnosis of potential cases. This overview article describes Clostridium difficile infection control and prevention methods and updates the most recent management strategies including a focus on the utilization and interpretation of laboratory diagnostic testing and appropriate treatment.

Entities:  

Keywords:  Clostridium difficile associated diarrhea; Clostridium difficile infection; diagnosis; laboratory testing; management; update

Mesh:

Year:  2017        PMID: 28210531      PMCID: PMC5304430     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN: 2165-8242


  40 in total

1.  Evaluation of diagnostic tests for Clostridium difficile infection.

Authors:  Jonathan Swindells; Nigel Brenwald; Nathan Reading; Beryl Oppenheim
Journal:  J Clin Microbiol       Date:  2009-12-23       Impact factor: 5.948

2.  The Daniel K. Inouye College of Pharmacy Scripts: The Development of Antimicrobial Stewardship Programs in Hawai'i.

Authors:  Roy Alan Sh Goo; Cherie Hl Chu; Melissa K Yoneda; Carolyn Sj Ma
Journal:  Hawaii J Med Public Health       Date:  2016-07

Review 3.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

4.  Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.

Authors:  Ilan Youngster; George H Russell; Christina Pindar; Tomer Ziv-Baran; Jenny Sauk; Elizabeth L Hohmann
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

5.  Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years.

Authors:  Philip Carling; Teresa Fung; Ann Killion; Norma Terrin; Michael Barza
Journal:  Infect Control Hosp Epidemiol       Date:  2003-09       Impact factor: 3.254

6.  Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.

Authors:  Susan M Novak-Weekley; Elizabeth M Marlowe; John M Miller; Joven Cumpio; Jim H Nomura; Paula H Vance; Alice Weissfeld
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

7.  Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.

Authors:  Elizabeth J Kvach; David Ferguson; Paul F Riska; Marie L Landry
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

Review 8.  Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.

Authors:  Oliver A Cornely; Dilip Nathwani; Cristina Ivanescu; Olatunji Odufowora-Sita; Peny Retsa; Isaac A O Odeyemi
Journal:  J Antimicrob Chemother       Date:  2014-07-28       Impact factor: 5.790

9.  The Role of Glutamate Dehydrogenase (GDH) Testing Assay in the Diagnosis of Clostridium difficile Infections: A High Sensitive Screening Test and an Essential Step in the Proposed Laboratory Diagnosis Workflow for Developing Countries like China.

Authors:  Jing-Wei Cheng; Meng Xiao; Timothy Kudinha; Zhi-Peng Xu; Lin-Ying Sun; Xin Hou; Li Zhang; Xin Fan; Fanrong Kong; Ying-Chun Xu
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

Review 10.  Clostridium difficile infection: a worldwide disease.

Authors:  Kristin E Burke; J Thomas Lamont
Journal:  Gut Liver       Date:  2014-01-13       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.